Clinical trial
Trial Of IRE in Cholangiocarcinoma (TOnIC): Phase II
NCT03769753 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trial Of IRE in Cholangiocarcinoma (TOnIC): Phase II
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 5, 2018
- Completion date
- August 16, 2021
- Enrollment
- 8 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.